<DOC>
	<DOC>NCT02789644</DOC>
	<brief_summary>A clinical study to investigate pharmacokinetics, metabolomics and biomarker in healthy elderly subject after ursodeoxycholic acid administration</brief_summary>
	<brief_title>Clinical Trial to Investigate Pharmacokinetics, Metabolomics and Biomarker in Elderly After UDCA Administration</brief_title>
	<detailed_description>This study has a randomized, open-label, two-treatment, one-sequence, multiple drug administration design. The purpose of this study is as follows; To investigate pharmacokinetics, metabolomics and biomarker in healthy elderly subject after ursodeoxycholic acid administration</detailed_description>
	<mesh_term>Ursodeoxycholic Acid</mesh_term>
	<criteria>Healthy Subjects aged 70 84 years A body mass index (BMI) in the range of 18.5 kg/m2 29.9 kg/m2. Good health based on complete medical history, physical examinations, vital signs, electrocardiography (ECG), and clinical laboratory evaluations. Subjects who have clinically significant disease of cardiovascular, respiratory, renal, endocrinological, hematological, gastrointestinal, neurological(central nervous system), psychiatric disorders or malignant tumor Subject judged not eligible for study participation by investigator</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>84 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Ursodeoxycholic acid</keyword>
	<keyword>Metabolomics/biomarker</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>